questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Transferases
Nitrogenous group transferases
Transaminases
Aspartate aminotransferases
Aspartate aminotransferases : Questions médicales fréquentes
Diagnostic
5
Enzymes
Tests de laboratoire
Aspartate aminotransférases
Valeurs de référence
Maladies hépatiques
Symptômes
Enzymes
Tests de laboratoire
Lésions hépatiques
Maladies musculaires
Symptômes
5
Aspartate aminotransférases
Maladies hépatiques
Douleur abdominale
Maladies hépatiques
Maladies cardiaques
Essoufflement
Asymptomatique
Tests de laboratoire
Prévention
5
Contrôles médicaux
Détection précoce
Traitements
5
Traitement
Changements de mode de vie
Médicaments
Suivi médical
Remèdes naturels
Santé hépatique
Consultation médicale
Symptômes
Alimentation
Maladies hépatiques
Complications
5
Maladies cardiaques
Évaluation médicale
Insuffisance hépatique
Complications
Facteurs de risque
5
Facteurs de risque
Alcoolisme
Diabète
Maladies hépatiques
Surpoids
Facteurs de risque
Antécédents familiaux
Maladies hépatiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aspartate aminotransferases : Questions médicales les plus fréquentes",
"headline": "Aspartate aminotransferases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aspartate aminotransferases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2026-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aspartate aminotransferases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Transaminases",
"url": "https://questionsmedicales.fr/mesh/D000637",
"about": {
"@type": "MedicalCondition",
"name": "Transaminases",
"code": {
"@type": "MedicalCode",
"code": "D000637",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.477.700"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aspartate aminotransferase, cytoplasmic",
"alternateName": "Aspartate Aminotransferase, Cytoplasmic",
"url": "https://questionsmedicales.fr/mesh/D024443",
"about": {
"@type": "MedicalCondition",
"name": "Aspartate aminotransferase, cytoplasmic",
"code": {
"@type": "MedicalCode",
"code": "D024443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.477.700.225.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aspartate aminotransferase, mitochondrial",
"alternateName": "Aspartate Aminotransferase, Mitochondrial",
"url": "https://questionsmedicales.fr/mesh/D024442",
"about": {
"@type": "MedicalCondition",
"name": "Aspartate aminotransferase, mitochondrial",
"code": {
"@type": "MedicalCode",
"code": "D024442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.477.700.225.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Aspartate aminotransferases",
"alternateName": "Aspartate Aminotransferases",
"code": {
"@type": "MedicalCode",
"code": "D001219",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daiki Kobayashi",
"url": "https://questionsmedicales.fr/author/Daiki%20Kobayashi",
"affiliation": {
"@type": "Organization",
"name": "Division of General Internal Medicine, Department of Medicine, St. Luke's International Hospital, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Kazuki Yamamoto",
"url": "https://questionsmedicales.fr/author/Kazuki%20Yamamoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Takeshi Kimura",
"url": "https://questionsmedicales.fr/author/Takeshi%20Kimura",
"affiliation": {
"@type": "Organization",
"name": "The Center for Preventive Medicine, St. Luke's International Hospital, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Takuro Shimbo",
"url": "https://questionsmedicales.fr/author/Takuro%20Shimbo",
"affiliation": {
"@type": "Organization",
"name": "Ohta Nishinouchi Hospital, Koriyama, Japan."
}
},
{
"@type": "Person",
"name": "Gjin Ndrepepa",
"url": "https://questionsmedicales.fr/author/Gjin%20Ndrepepa",
"affiliation": {
"@type": "Organization",
"name": "Deutsches Herzzentrum München, Technische Universität, Munich, Germany. Electronic address: ndrepepa@dhm.mhn.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Associations of alanine aminotransferase/aspartate aminotransferase with insulin resistance and β-cell function in women.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37188859",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-35001-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "The aspartate aminotransferase to alanine aminotransferase ratio: A novel indicator for skeletal muscle mass in Chinese community adults.",
"datePublished": "2023-09-09",
"url": "https://questionsmedicales.fr/article/37837772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nut.2023.112214"
}
},
{
"@type": "ScholarlyArticle",
"name": "Crystal structure of an aspartate aminotransferase Lpg0070 from Legionella pneumophila.",
"datePublished": "2023-11-10",
"url": "https://questionsmedicales.fr/article/37984176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbrc.2023.149230"
}
},
{
"@type": "ScholarlyArticle",
"name": "Non-linear association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill older patients: A retrospective cohort study.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/37917784",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0293749"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of alanine aminotransferase/aspartate aminotransferase ratio and high-density lipoprotein for predicting neonatal adverse outcomes associated with intrahepatic cholestasis of pregnancy.",
"datePublished": "2024-06-24",
"url": "https://questionsmedicales.fr/article/38938614",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.17613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transferases",
"item": "https://questionsmedicales.fr/mesh/D014166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nitrogenous group transferases",
"item": "https://questionsmedicales.fr/mesh/D019884"
},
{
"@type": "ListItem",
"position": 6,
"name": "Transaminases",
"item": "https://questionsmedicales.fr/mesh/D000637"
},
{
"@type": "ListItem",
"position": 7,
"name": "Aspartate aminotransferases",
"item": "https://questionsmedicales.fr/mesh/D001219"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aspartate aminotransferases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aspartate aminotransferases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aspartate aminotransferases",
"description": "Comment mesurer les niveaux d'AST ?\nQuels sont les niveaux normaux d'AST ?\nQuand faut-il tester l'AST ?\nQuelles autres enzymes sont testées avec l'AST ?\nQue signifie un taux élevé d'AST ?",
"url": "https://questionsmedicales.fr/mesh/D001219#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aspartate aminotransferases",
"description": "Quels symptômes indiquent une élévation de l'AST ?\nL'AST élevée cause-t-elle des symptômes ?\nComment l'AST est-elle liée à la douleur abdominale ?\nQuels signes de maladie cardiaque sont associés à l'AST ?\nL'AST élevée est-elle toujours symptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D001219#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aspartate aminotransferases",
"description": "Comment prévenir l'élévation de l'AST ?\nLe vaccin contre l'hépatite aide-t-il ?\nL'exercice régulier influence-t-il l'AST ?\nLes contrôles médicaux réguliers sont-ils importants ?\nLe stress affecte-t-il l'AST ?",
"url": "https://questionsmedicales.fr/mesh/D001219#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aspartate aminotransferases",
"description": "Comment traiter une élévation de l'AST ?\nLes médicaments peuvent-ils affecter l'AST ?\nY a-t-il des remèdes naturels pour l'AST élevée ?\nQuand consulter un médecin pour l'AST ?\nL'alimentation influence-t-elle l'AST ?",
"url": "https://questionsmedicales.fr/mesh/D001219#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aspartate aminotransferases",
"description": "Quelles complications peuvent survenir avec l'AST élevée ?\nL'AST élevée est-elle un signe de cancer ?\nComment l'AST élevée affecte-t-elle le foie ?\nLes maladies cardiaques sont-elles liées à l'AST ?\nL'AST élevée peut-elle entraîner une insuffisance hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D001219#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aspartate aminotransferases",
"description": "Quels sont les facteurs de risque d'AST élevée ?\nL'âge influence-t-il les niveaux d'AST ?\nLe diabète est-il un facteur de risque pour l'AST ?\nLe surpoids affecte-t-il l'AST ?\nLes antécédents familiaux influencent-ils l'AST ?",
"url": "https://questionsmedicales.fr/mesh/D001219#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer les niveaux d'AST ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux d'AST sont mesurés par une analyse sanguine standard."
}
},
{
"@type": "Question",
"name": "Quels sont les niveaux normaux d'AST ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux normaux d'AST varient entre 10 et 40 unités par litre."
}
},
{
"@type": "Question",
"name": "Quand faut-il tester l'AST ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test d'AST est recommandé en cas de symptômes hépatiques ou de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles autres enzymes sont testées avec l'AST ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'alanine aminotransférase (ALT) et la phosphatase alcaline sont souvent testées."
}
},
{
"@type": "Question",
"name": "Que signifie un taux élevé d'AST ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé d'AST peut indiquer des lésions hépatiques ou musculaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une élévation de l'AST ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et nausées."
}
},
{
"@type": "Question",
"name": "L'AST élevée cause-t-elle des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'élévation de l'AST elle-même ne cause pas de symptômes, mais indique une condition sous-jacente."
}
},
{
"@type": "Question",
"name": "Comment l'AST est-elle liée à la douleur abdominale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une douleur abdominale peut signaler une maladie hépatique, souvent associée à une élévation de l'AST."
}
},
{
"@type": "Question",
"name": "Quels signes de maladie cardiaque sont associés à l'AST ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques et des essoufflements peuvent être liés à une élévation de l'AST."
}
},
{
"@type": "Question",
"name": "L'AST élevée est-elle toujours symptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, une élévation de l'AST peut être asymptomatique, nécessitant des tests pour évaluer la cause."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'élévation de l'AST ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez l'alcool, maintenez un poids santé et adoptez une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Le vaccin contre l'hépatite aide-t-il ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre l'hépatite A et B peut prévenir des infections hépatiques augmentant l'AST."
}
},
{
"@type": "Question",
"name": "L'exercice régulier influence-t-il l'AST ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut aider à maintenir des niveaux d'AST normaux et à améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers peuvent détecter des problèmes hépatiques avant qu'ils n'affectent l'AST."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il l'AST ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à des problèmes de santé, y compris des niveaux d'AST élevés."
}
},
{
"@type": "Question",
"name": "Comment traiter une élévation de l'AST ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils affecter l'AST ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent augmenter les niveaux d'AST, nécessitant un suivi médical."
}
},
{
"@type": "Question",
"name": "Y a-t-il des remèdes naturels pour l'AST élevée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des remèdes comme le chardon-Marie peuvent soutenir la santé hépatique, mais consultez un médecin."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour l'AST ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si vous avez des symptômes ou des niveaux d'AST anormaux persistants."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle l'AST ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut aider à maintenir des niveaux d'AST sains, surtout en cas de maladie hépatique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'AST élevée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies hépatiques avancées, des cirrhoses ou des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "L'AST élevée est-elle un signe de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une élévation de l'AST peut être associée à des cancers hépatiques, nécessitant des examens approfondis."
}
},
{
"@type": "Question",
"name": "Comment l'AST élevée affecte-t-elle le foie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés d'AST peuvent indiquer des lésions hépatiques, entraînant des complications graves."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques sont-elles liées à l'AST ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés d'AST peuvent indiquer des lésions cardiaques, nécessitant une évaluation."
}
},
{
"@type": "Question",
"name": "L'AST élevée peut-elle entraîner une insuffisance hépatique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une élévation prolongée de l'AST peut contribuer à une insuffisance hépatique sévère."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'AST élevée ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'alcoolisme, l'obésité, les hépatites virales et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux d'AST ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux d'AST peuvent augmenter avec l'âge en raison de divers facteurs de santé."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour l'AST ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque de maladies hépatiques, entraînant une élévation de l'AST."
}
},
{
"@type": "Question",
"name": "Le surpoids affecte-t-il l'AST ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids est un facteur de risque majeur pour l'élévation des niveaux d'AST."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils l'AST ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies hépatiques peuvent augmenter le risque d'AST élevée."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Division of General Internal Medicine, Department of Medicine, St. Luke's International Hospital, Tokyo, Japan.
Department of Epidemiology, St. Luke's International University Graduate School of Public Health, Tokyo, Japan.
Fujita Health University, Toyoake, Japan.
Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
The Center for Preventive Medicine, St. Luke's International Hospital, Tokyo, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Ohta Nishinouchi Hospital, Koriyama, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Deutsches Herzzentrum München, Technische Universität, Munich, Germany. Electronic address: ndrepepa@dhm.mhn.de.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Deutsches Herzzentrum München, Technische Universität, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiology, Osaka Medical College, Takatsuki, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH, United States. Electronic address: timothy.mueser@utoledo.edu.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN, United States.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH, United States; Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN, United States.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Hygiene, Public Health and Preventive Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. h-ochiai@med.showa-u.ac.jp.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Hygiene, Public Health and Preventive Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Hygiene, Public Health and Preventive Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
All Japan Labor Welfare Foundation, 6-16-11 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan.
Publications dans "Aspartate aminotransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Hygiene, Public Health and Preventive Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Publications dans "Aspartate aminotransferases" :
1 publication dans cette catégorie
Affiliations :
Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Aspartate aminotransferases" :
1 publication dans cette catégorie
Affiliations :
Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Aspartate aminotransferases" :
1 publication dans cette catégorie
Affiliations :
Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Aspartate aminotransferases" :
1 publication dans cette catégorie
Affiliations :
Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China. junqiniu@aliyun.com.
Publications dans "Aspartate aminotransferases" :
We tested whether alanine aminotransferase/aspartate aminotransferase (ALT/AST), a marker of hepatosteatosis, associates with insulin resistance, β-cell function and postglucose glycemia. We studied 3...
The aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio, an indicator for liver fibrosis, could be easily detected in clinical practice. The aim of this study was to examine the ass...
We enrolled 2644 participants, age ≥18 y, undergoing bioelectrical impedance analysis and liver function test. Univariate and multivariate logistic regression models were used to analyze the effect of...
When the AST/ALT ratio was regarded as a categorical variable, AST/ALT quartiles 9-2.19) kept independent effects on the presence of LMM status. When it was regarded as a continuous variable, each uni...
In general, the high AST/ALT ratio was an independent adverse indicator of the presence of LMM....
Legionella pneumophila aspartate aminotransferase (Lpg0070) is a member of the transaminase and belongs to the pyridoxal 5'-phosphate (PLP)-dependent superfamily. It is responsible for the transfer of...
The aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio has been shown to be associated with poor clinical outcomes across various patient groups. However, little is unclear about t...
In this retrospective cohort study, we extracted elderly patients (age ≥ 65 years) from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The primary outcome was in-hospital mort...
Among the 13,358 eligible patients, the mean age was 77.6 years, 7,077 patients (52.9%) were male, and 2,511 patients (18.8%) died in hospital. The AST/ALT ratio was found to be independently associat...
In critically ill older patients, the association between the AST/ALT ratio and in-hospital mortality was non-linear and showed a saturation effect. An elevated AST/ALT ratio was significantly associa...
To determine the association between lipid metabolism and intrahepatic cholestasis of pregnancy (ICP), and explore the value of maternal alanine aminotransferase/aspartate aminotransferase (ALT/AST) a...
A total of 147 pregnant women with ICP admitted to The Fourth Hospital of Shijiazhuang and 120 normal pregnant women in the same period were selected in this study. The Mann-Whitney U test and Chi-squ...
Among 147 women with ICP, 122 women had total bile acid (TBA) levels of 10-39.9 µmol/L, and 25 had TBA ≥ 40 µmol/L. There was significantly lower gestational age in patients with severe ICP than in th...
The levels of higher ALT/AST and lower HDL were significantly associated with the risk of ICP-related adverse neonatal outcomes. Moreover, ALT/AST combined with HDL has moderate clinical value in pred...
The purpose of this study was to investigate the relationship between preoperative aspartate aminotransferase-to-platelet ratio index (APRI) and postoperative complications following total hip arthrop...
All THA for osteoarthritis patients from 2007 to 2020 within the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database were included in this study. Subjects...
In total, 104,633 primary THA patients were included in this study. Of these, 103,678 (99.1%) were in the normal APRI group, 444 (0.4%) had some liver damage, 256 (0.2%) had significant fibrosis, and ...
Abnormal preoperative APRI is linked with an increasing number of adverse outcomes following THA for osteoarthritis for patients across the United States....
Level I....
Cause of Kawasaki disease (KD) is unknown. KD is often resistant to treatment with intravenous immunoglobulin (IVIG). Sano's score, which is derived from total bilirubin (TBIL), aspartate aminotransfe...
The association between liver fibrosis and oral or gut microbiota has been studied before. However, epidemiological studies in the general population are limited owing to the difficulty of noninvasive...
Anti-coagulation is the cornerstone management of acute pulmonary embolism (PE), which is a double-edged sword, as it increases the risk of bleeding. Thus, predicting bleeding risk is necessary. The l...
A single-center, retrospective analysis of patients with acute PE was performed. First, the authors studied the association between liver dysfunction indexes and the 1-month bleeding risk. Then, they ...
Among 469 patients with acute PE, 34 patients (7.2%) had bleeding events within 1 month after the onset. The levels of aspartate aminotransferase (AST) were higher in the bleeding group compared with ...
In PE patients, AST is an independent factor in predicting the 1-month bleeding risk, and a novel joint model that combines AST and PE-SARD score improved the predictive efficiency for the 1-month ble...
Microwave ablation (MWA) is widely used to eliminate colorectal liver metastases (CRLM). However, the risk of tumor recurrence is difficult to predict due to lack of reliable clinical and biological m...
A retrospectively analyzed 192 CRLM patients who underwent MWA from January 2013 to December 2017. Pre-ablation GSR was classified into high (≤ 2.34) or low (> 2.34) using the upper quartile value. Th...
High GSR was significantly associated with males (P = 0.041), the presence of cholelithiasis (P = 0.012), but not pre-ablation chemotherapy (P = 0.355), which caused significantly increased levels of ...
Our findings suggest that the pre-ablation GSR can be considered as a promising prognostic indicator for poor prognosis of patients with CRLM underwent MWA....
Not applicable....